Background: Chronic renal failure (CRF) is a major public health hazard. Anemia is an accompaniment and independent risk factor for the development of cardiac dysfunction and responsible for 40% to 50% deaths in CRF patients. For this reason, effective erythropoiesis to correct anemia by erythropoietin therapy and maintenance of target iron level is very much important. Subjects and Methods: The present study has been designed to observe iron status in different stages of CRF patients suffering from anemia. For this purpose, 65 male CRF patients with anemia and 25 healthy male (control) subjects, in the age group of 30-50 years were selected randomly from BSMMU outpatient department. Iron level, hemoglobin and creatinine clearance were estimated by usual laboratory technique. Data were analyzed statistically by ANOVA and Pearson's correlation coefficient test. Among 65 CRF patients, 15 were mild, 25 were moderate and 25 were reported severe renal failure with anemia. Results: The mean serum iron, transferrin saturation and ferritin were significantly (P < 0.001) lower in moderate but severe in CRF patients with anemia compared to those of healthy subjects and these values were also significantly (P < 0.001) lower in severe CRF than those of mild and moderate groups of patients. On the other hand, total iron binding capacity was significantly (P < 0.001) higher only in severe group of CRF patients compared to healthy, mild and moderate group of CRF patients. In addition, 72% severe group of CRF patients had serum ferritin and 28% had transferrin saturation below the target level (≥100 ng/ml serum ferritin & ≥20% transferrin saturation). Decreasing iron status which is more marked in severe CRF patients are suggestive of iron deficiency and iron status below the target level in severe CRF patients indicate inadequate iron store. Also, a significantly (P < 0.001) decreasing hemoglobin concentration is observed in severe CRF case compared to those of mild and moderate CRF patients with anemia. Conclusion: From the present study it may be concluded that changes in iron status occur in CRF patients with anemia and these changes vary along with severity of CRF.
INTRODUCTION
Chronic renal failure (CRF) is one of the major public health problems throughout the world. 1 In Bangladesh, 5% of total population have been suffering from renal diseases, among them, about 15,000 to 20,000 patients are dying due to CRF each year. 2 With progression of disease various abnormalities developed. 3 Anemia is one of the most consistent and severe hematological complication in this group of population. 4 CRF is associated with higher level of serum creatinine along with lower creatinine clearance and according to these values the disease can be categorized into mild, moderate and severe one. 5 Normal serum iron concentration and total iron binding capacity has been observed in different stages of CRF. 6, 7 In contrast, lower serum iron and higher TIBC were also reported in a few number of patients suffering from severe CRF. 4 Recently, more interest has been shown to assess iron status by measuring transferrin saturation and serum ferritin level, as transferrin saturation reflects the amount of iron immediately available for hemoglobin synthesis and ferritin reflects total body iron store. 8 Again, it has also been reported that a target level of ≥100 ng/ml of serum ferritin and transferrin saturation of ≥20% should have to be maintained in CRF patients with anemia for effective erythropoiesis before erythropoietin therapy. Some investigators observed these values below target levels in some of the mild and moderate but in most of the cases of severe CRF patients suffering from anemia. 9 In our country, a major number of kidney patients are suffering from CRF associated with anemia. 2 Anemia is an independent risk factor for development of cardiac dysfunction like increased cardiac output, cardiac enlargement, left ventricular hypertrophy and congestive cardiac failure. In addition, it may decrease the quality of life and exercising capacity. 8 Cardiovascular diseases account for 40% to 50% of deaths in CRF patients, and mortality rate in this group of patients are 15 times higher than that of general population. 7 Again, earlier and effective correction of anemia in CRF patients may be helpful in preventing the development and subsequent progression of disease. Moreover, it may also increase the duration of pre-dialysis period and thereby decreases hospitalization. 10 For correction of anemia with erythropoietin therapy, more importance has been given on detection of target level of ferritin and transferrin saturation. 8, 9 Again 70% of our population has been suffering from anemia due to iron deficiency. 11 So early detection of iron status is more important for better management of CRF patients with anemia. Though various observations have been reported from different countries, no such study has yet been reported in our country regarding iron status in CRF patients along with the severity of disease. Therefore, the present study is designed to observe the iron status in different stages of CRF with anemia.
MATERIALS AND METHODS
The study was carried out to observe the iron status in patients with different stages of CRF. For this, 65 male CRF patients with anemia and 25 healthy male (control) subjects in the age group of 30-50 years were selected randomly. Among them 15 were mild, 25 were moderate and 25 were in severe group. The diagnosed CRF patients were taken from the outpatient Department of Nephrology, BSMMU, who fulfill the inclusion criteria-CRF patients with anemia hemoglobin concentration <12 gm/dl and Ccr 30-50 ml/ min, Ccr 16-29 ml/min, Ccr 5-15 ml/min were respectively mild, moderate and severe CRF patients 5, 8 in the experimental group. Apparently healthy subjects were selected from kidney donor attending outpatient department of nephrology, BSMMU. CRF patients with history of kidney transplantation, associated liver disease, non-renal origin of anemia (previous history of GIT bleeding, malignancy, chronic TB), history of erythropoietin therapy and history of blood transfusion during the last three months 6, 12 were excluded from the study. After selection of the subjects, objectives and procedures of the study were explained and then verbal consent was obtained from the patient. Blood and urine samples were taken from each study subject for measurement of hemoglobin, biochemical parameters and creatinine clearance. Adequate amount of blood was taken for measurement of hemoglobin and rest was kept in standing position till it clotted. Then the serum was collected in a labeled test tube for measurement of serum creatinine, serum iron, total iron binding capacity and serum ferritin. A labeled plastic container was supplied to each of the study subject for collection of 24-hour urine. The 24-hour urine volume was measured. Then, 1 ml of urine from this sample was taken into a cylinder for measurement of urinary creatinine concentration and from that creatinine clearance was measured.
Statistical analysis was done using ANOVA test and relationship between different parameters was done by Pearson's correlation coefficient test.
RESULT
The mean (±SD) hemoglobin concentrations in control and CRF patients with anemia in different stages are shown in Table 1 . The mean hemoglobin concentrations were significantly lower (P < 0.001) in mild, moderate and severe CRF patients compared to that of healthy subjects. Again this concentration was also significantly lower (P < 0.001) in severe than those of mild and moderate CRF patients and also in moderate than that of mild CRF patients. The mean (±SD) serum iron, transferring saturation values and serum ferritine levels in control and CRF patients with anemia in different stages are shown in Table 2 .
The mean serum iron and ferritin level in moderate and severe CRF patients were significantly lower (P < 0.001) than that of healthy subjects. Again, in severe CRF patients these levels were significantly lowered (P < 0.001) than those of mild and moderate cases.
The mean±SD total iron binding capacities in healthy subjects & in mild, moderate, severe CRF patients are shown in Table 3 .
The mean total iron binding capacities in severe CRF patients was significantly higher (P < 0.001) than that of healthy subjects. Again, in severe CRF patients, total iron Notes: Control = healthy subjects, CRF = chronic renal failure, results are expressed as mean (±SD), n = number of subjects.
binding capacity was significantly higher (P < 0.001) than those of mild and moderate CRF patients. Frequency distribution of serum ferritin and transferring saturation were done in different stages of CRF with anemia and the results are shown in Tables 4 and 5 .
Among the mild CRF patients, all (100%) had ferritin level >100 ng/ml and transferrin saturation >20% in mild and also in moderate CRF cases. However, 12% out of 25 moderate cases had <100 ng/ml serum ferritin level. Similarly, in severe CRF patients 28% had ferritin level >100 ng/ml, transferring saturation <20% and again 72% had <100 ng/ml serum ferritin level, >20% transferrin saturation level.
DISCUSSION
The present study was undertaken to observe iron status in different stages of CRF patients suffering from anemia. For Notes: Control = healthy subjects, CRF = chronic renal failure, n = numbers of subjects. Notes: n = number of subjects, CRF= chronic renal failure.
this purpose, mild, moderate and severe CRF patients with anemia were studied and their iron status was measured by estimating serum iron, ferritin, TIBC and by calculating transferrin saturation along with the estimation of hemoglobin concentration. All these parameters were studied in age and sex matched with healthy subjects for control and also to find out their baseline data in this group of population. All the subjects belong to poor socio-economical status. In this study, hemoglobin and iron level in healthy subjects were within normal range. The mean hemoglobin concentration was significantly (P < 0.001) lower in moderate and severe than that of mild CRF and also between moderate and severe CRF patients suffering from anemia. These hemoglobin concentrations observed in moderate and severe cases were markedly lower in comparison to mild cases in this series of CRF patients with anemia. These results were also consistent with the findings reported by other investigators. 6,7,9,13,14 The mean serum iron level in moderate and severe CRF cases with anemia compared to that of healthy subjects were statistically significant (P < 0.001). Similar lower level of serum iron was also observed in CRF patients. 6 Again, serum iron level (P < 0.001) was significantly lower in severe than those of mild and moderate CRF patients with anemia. However this lower level was not statistically significant in moderate cases in comparison to that of mild group. Similar observation was also reported in severe CRF patients, 4 while some other investigators also reported similar findings in moderate and severe CRF patients. 13 The mean serum TIBC was higher in mild, moderate and severe CRF patients associated with anemia than that of healthy subjects though in all the groups it was within normal range. Similar findings were also observed by some workers. 7 The differences of this level in severe CRF with anemia compared to that of healthy subjects were statistically significant (P < 0.001). Similar higher levels were also reported in similar groups of patients. 6 Again, serum TIBC was significantly (P < 0.001) higher in severe than those of mild and moderate CRF patients associated with anemia. However, this higher level was not statistically significant in moderate cases in comparison to that of mild cases. Some workers also observed similar higher level in moderate and severe CRF. 13 The mean transferrin saturations observed both in moderate and severe CRF patients with anemia to those of healthy subjects were statistically significant (P < 0.001). These are consistent with findings of some investigators. 7 On the other hand, these mean levels were significantly (P < 0.001) lower in severe compared to those of mild and moderate CRF with anemia. However, the transferrin saturation observed in moderate cases compared to that of mild cases was not statistically significant. Again workers of different countries also observed similar lower transferring saturation in CRF with anemia patients, 15 while others reported similar lower value in severe group of patients. 16 The mean serum ferritin levels were lower in mild, moderate and severe CRF patients with anemia compared to that of healthy subjects. Though a tendency to decrease was observed, these levels were within normal range in all the three groups of CRF patients. Similar findings were also reported by some investigators. 7 On the other hand, significant (P < 0.001) differences of this level were observed in severe cases compared to those of mild and moderate CRF. However, in moderate cases, statistically no significant difference was observed than that of mild CRF. Similar lower level was also reported by workers of different countries. 9, 13 While some investigators also found similar lower level in severe group of patients. 15 The transferrin saturation of ≥20% and serum ferritin level ≥100 ng/ml is considered as a target level before erythropoietin therapy in CRF patients with anemia. In this study, transferrin saturation was above the target level in all (100%) the mild and moderate CRF patients. On the other hand, serum ferritin level in moderate CRF with anemia 76% of the patients had above and 24% below this target level. Again, in 72% of the patients suffering from severe CRF had above, while 28% had below the target level of transferrin saturation. On the other hand, serum ferritin concentration, 28% patients had above and 72% had below this target level. In a similar type of study, Shaheda Khanam et al some workers reported that 19% of mild, 35% of moderate and 69% of severe CRF patients had transferrin saturation below the reference target level. 8 Similar type of findings was also reported by investigators who observed 52% of severe had below the target level. 17 Again, some investigators reported that 37% of mild, 44% of moderate and 44% of severe CRF patients had serum ferritin below the target level. 9 Different investigators made various suggestions about the causes of this hemoglobin concentration changes in patients suffering from CRF.. Workers of different countries suggested that erythropoietin deficiency due to decline in functional renal tissue is a causative factor for decrease in RBC production in CRF patients suffering anemia. 6, 8, 9 As anorexia, nausea and vomiting are the common features of CRF patients, less dietary intake of nutrients needed for erythropoiesis might also be responsible for anemia in this group of patients. Moreover, some investigators suggested that CRF patients are on protein-restricted diet which might also have some role for anemia in these series of patients. 4 In supporting this explanation, iron deficiency may contribute to the development of anemia in severe CRF patients. 8 Workers from different countries also suggested that various factors might be involved for lowering of iron status in patients suffering from CRF associated with anemia. These factors are possibly due to defective iron absorption, frequent blood test and also reduced dietary intake of iron as a consequence of gastrointestinal symptoms, like nausea, anorexia and vomiting. 6, 7, 9 Again, in majority cases impaired platelet function may also contribute to deficiency of iron in patients suffering from severe CRF with anemia. 18 It is further suggested that lower serum iron and normal serum levels may occur when severe CRF is associated with chronic infection. Some investigators also reported that for effective erythropoiesis by erythropoietin therapy, it is necessary to ensure sufficient availability of iron in patients suffering from CRF. 8 They further suggested that serum ferritin level should be equal to or more than 100 ng/ml and transferrin saturation equal to or more than 20% for effective erythropoiesis in patients suffering from CRF with anemia.
In the present study, hemoglobin concentration gradually lowered from mild to moderate and was markedly lowered in severe CRF patients with anemia. Erythropoietin deficiency is the primary cause of anemia in CRF and the findings of this study are also in favor of gradual destruction of erythropoietin secreting cells of the kidney in different stages of CRF though it was not possible to measure their erythropoietin levels. In addition, markedly lowered hemoglobin concentration in severe CRF was also likely due to less dietary intake of iron and vitamins as most of them were suffering from GIT symptoms, like anorexia, nausea and vomiting and they were also socio-economically poor. Moreover, maximum restriction of dietary protein usually advised in CRF also plays a role for marked change of hemoglobin in this group. Lower serum iron, ferritin, transferrin saturation with higher total iron binding capacity in CRF patients are suggestive of iron deficiency. It is further supported by positive correlation of serum iron, ferritin, transferrin saturation and negative correlation of total iron binding capacity with creatinine clearance. Lowered iron observed in these series of CRF patients are likely to be due to defective iron absorption, less intake of iron containing diet and GIT symptoms. Factors affecting iron absorption was not studied in the CRF patients of the present series, but other factors supported by indirect evidences from the history. Again, iron status depends on the severity of CRF which is also indicated by significantly decreased level of serum iron, ferritin, transferrin saturation and also significantly higher level of TIBC in severe CRF patients. The level of serum ferritin & transferrin saturation in severe cases was below the target level while only ferritin level in moderate CRF cases was below the target level which indicate inadequate iron status in patients of these series.
CONCLUSION
From the present study it may be concluded that changes in iron status occur in CRF patients with anemia and these changes vary with severity of CRF. To correct anemia maintenance of target iron level is very much important for effective erythropoiesis by erythropoietin therapy. Further study on large sample using bone marrow biopsy with iron staining is recommended.
